Your browser doesn't support javascript.
loading
Assessment of type I interferon response in routine practice in France in 2022.
Nombel, Anais; Foray, Anne Perrine; Garnier, Lorna; Lombard, Christine; Hachulla, Eric; Bader-Meunier, Brigitte; Georgin-Lavialle, Sophie; Melki, Isabelle; Walzer, Thierry; Belot, Alexandre; Viel, Sebastien.
Afiliação
  • Nombel A; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France.
  • Foray AP; International Center of Infectiology Research (CIRI), INSERM U1111, CNRS, UMR5308, ENS of Lyon, Claude Bernard University Lyon 1, Lyon, France.
  • Garnier L; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France.
  • Lombard C; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France.
  • Hachulla E; Immunology Laboratory, Hôpital Lyon-Sud, Hospices Civils de Lyon, Lyon, France.
  • Bader-Meunier B; Département de Médecine Interne et d'Immunologie Clinique, Centre National de Référence Maladies Systémiques et Auto-immunes Rares Nord et Nord-Ouest de France (CeRAINO), European Reference Network on Rare Connective Tissue and Musculoskeletal Diseases Network (ReCONNECT), Université de Lille, CHU L
  • Georgin-Lavialle S; Department of Paediatric Hematology-Immunology and Rheumatology, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Necker-Enfants Malades Hospital, AP-HP, Paris, France.
  • Melki I; Service Médecine Interne, Centre de référence des maladies autoinflammatoires et des amyloses (CEREMAIA), Hôpital Tenon, AP-HP, Paris, France.
  • Walzer T; General Paediatrics, Department of Infectious Disease and Internal Medicine, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Robert Debré Mother-Child University Hospital, AP-HP, Paris, France.
  • Belot A; International Center of Infectiology Research (CIRI), INSERM U1111, CNRS, UMR5308, ENS of Lyon, Claude Bernard University Lyon 1, Lyon, France.
  • Viel S; International Center of Infectiology Research (CIRI), INSERM U1111, CNRS, UMR5308, ENS of Lyon, Claude Bernard University Lyon 1, Lyon, France sebastien.viel@inserm.fr alexandre.belot@chu-lyon.fr.
RMD Open ; 9(2)2023 06.
Article em En | MEDLINE | ID: mdl-37321666
An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interferon pathway assay that has been set up and used routinely since 2018 in Lyon, France.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reumatologia / Interferon Tipo I Limite: Humans País/Região como assunto: Europa Idioma: En Revista: RMD Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reumatologia / Interferon Tipo I Limite: Humans País/Região como assunto: Europa Idioma: En Revista: RMD Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido